KAPA Kairos Pharma, Ltd.

Fundamentals / CIK 0001962011 / USD

Kairos Pharma, Ltd. reported $4.37M in total assets and a net loss of $6.39M through December 31, 2025 from SEC EDGAR filings.

Audited annual (10-K / 20-F) and quarterly (10-Q) statements parsed directly from SEC EDGAR CompanyFacts. Open KAPA in the Convexity terminal for live prices, valuation multiples, transcripts, and insider flow.

Annual revenue and net income

3 fiscal years (2023 to 2025), reported in USD.

$0$0$0-$5.09MFY 2023 Net Income: -$1.81M2023FY 2024 Net Income: -$2.60M2024FY 2025 Net Income: -$5.45M2025

Financial statements and ratios

Reported in USD. Per-share figures and share counts are adjusted for stock splits from SEC filings.

Income Statement (Annual) · Reported in USD · Newest filing period first.

Income Statement Dec 31 Dec 31 Dec 31
Research & Development $2.13M $414K $82K
Total Operating Expenses $5.57M $2.34M $1.71M
Operating Income -$5.57M -$2.34M -$1.71M
Interest Expense -- $35K $42K
Net Income -$5.45M -$2.60M -$1.81M
Basic EPS -$2.10 -$1.61 -$1.19
Diluted EPS -$2.10 -$1.61 -$1.19
Basic Shares Outstanding 2.6M 1.6M 1.5M
Diluted Shares Outstanding 2.6M 1.6M 1.5M

Income Statement (Quarterly) · Reported in USD · Newest filing period first.

Income Statement 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Research & Development $892K $619K $684K $538K $608K $496K $493K $172K
Total Operating Expenses $2.01M $1.42M $1.69M $1.42M $1.44M $1.46M $1.27M $1.45M
Operating Income -$2.01M -$1.42M -$1.69M -$1.42M -$1.44M -$1.46M -$1.27M -$1.45M
Interest Expense -- -- -- -- -- -- -- $0
Net Income -$1.98M -$1.39M -$1.65M -$1.36M -$1.40M -$1.42M -$1.26M -$980K
Basic EPS -$0.59 -$0.42 -$0.56 -- -$0.48 -$0.56 -$0.56 --
Diluted EPS -$0.59 -$0.42 -$0.56 -- -$0.48 -$0.56 -$0.56 --
Basic Shares Outstanding 3.3M 3.1M 3.0M -- 2.9M 2.5M 2.3M --
Diluted Shares Outstanding 3.3M 3.1M 3.0M -- 2.9M 2.5M 2.3M --

Balance Sheet (Annual) · Reported in USD · Newest filing period first.

Balance Sheet Dec 31 Dec 31 Dec 31
Cash & Cash Equivalents $4.49M $1.27M $93K
Cash & Short-Term Investments $4.49M $1.27M $93K
Total Current Assets $5.39M $4.17M $101K
Intangible Assets $62K $222K $382K
Total Non-Current Assets $1.15M $1.60M $864K
Total Assets $6.54M $5.77M $965K
Total Current Liabilities $199K $992K $2.40M
Total Non-Current Liabilities $0 $0 $638K
Total Liabilities $199K $992K $3.04M
Common Stock $3.0K $14K $11K
Retained Earnings -$14.26M -$8.81M -$6.21M
Total Stockholders' Equity $6.34M $4.78M -$2.08M
Total Equity $6.34M $4.78M -$2.08M

Balance Sheet (Quarterly) · Reported in USD · Newest filing period first.

Balance Sheet 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Cash & Cash Equivalents $3.12M $2.63M $3.67M $4.49M $5.58M $3.03M $3.62M $1.27M
Cash & Short-Term Investments $3.12M $2.63M $3.67M $4.49M $5.58M $3.03M $3.62M $1.27M
Total Current Assets $3.35M $3.17M $4.44M $5.39M $6.66M $4.84M $6.05M $4.17M
Intangible Assets -- $191K $22K $62K $102K $142K $182K $222K
Total Non-Current Assets $1.02M $1.28M $1.30M $1.15M $1.41M $1.83M $1.89M $1.60M
Total Assets $4.37M $4.46M $5.74M $6.54M $8.07M $6.67M $7.94M $5.77M
Total Current Liabilities $495K $265K $431K $199K $402K $676K $805K $992K
Total Non-Current Liabilities $0 $0 $0 $0 $0 $0 $0 $0
Total Liabilities $495K $265K $431K $199K $402K $676K $805K $992K
Common Stock $4.0K $21K $21K $3.0K $21K $18K $16K $14K
Retained Earnings -$19.29M -$17.30M -$15.92M -$14.26M -$12.90M -$11.50M -$10.08M -$8.81M
Total Stockholders' Equity $3.88M $4.19M $5.31M $6.34M $7.66M $6.00M $7.13M $4.78M
Total Equity $3.88M $4.19M $5.31M $6.34M $7.66M $6.00M $7.13M $4.78M

Cash Flow Statement (Annual) · Reported in USD · Newest filing period first.

Cash Flow Statement Dec 31 Dec 31 Dec 31
Net Income -$5.45M -$2.60M -$1.81M
Operating Cash Flow -$3.44M -$3.96M $81K
Financing Cash Flow $6.66M $5.13M -$425K
Net Change in Cash $3.22M $1.18M -$344K

Cash Flow Statement (Quarterly) · Reported in USD · Newest filing period first.

Cash Flow Statement 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Net Income -$1.98M -$1.39M -$1.65M -$1.36M -$1.40M -$1.42M -$1.26M -$980K
Operating Cash Flow -$979K -$1.01M -$1.04M -$1.08M -$838K -$805K -$714K -$1.80M
Financing Cash Flow $1.48M -$37K $220K $0 $3.38M $223K $3.06M -$142K
Net Change in Cash $499K -$1.05M -$816K -$1.08M $2.54M -$582K $2.34M -$1.95M

Margins, returns, leverage, liquidity, and year-over-year growth computed directly from SEC EDGAR statement levels. Multi-year figures show cumulative per-share growth.

Ratios & Growth Dec 31 Dec 31 Dec 31
Return on Equity (ROE) -85.9% -54.5% --
Return on Assets (ROA) -83.3% -45.1% -187.8%
Current Ratio 27.07x 4.20x 0.04x
Quick Ratio 22.57x 1.28x 0.04x
Operating Cash Flow Growth (YoY) -- -4982.7% --

Quarterly margins, ROE, and ROA use trailing-twelve-month (TTM) flows summed across four contiguous quarters. Growth rates are true year-over-year comparisons against the same quarter a year earlier.

Ratios & Growth 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Return on Equity (ROE) -164.9% -138.5% -109.9% -85.9% -66.0% -78.6% -49.7% -54.5%
Return on Assets (ROA) -146.2% -130.3% -101.7% -83.3% -62.8% -70.6% -44.6% -45.1%
Current Ratio 6.77x 11.98x 10.31x 27.07x 16.56x 7.16x 7.52x 4.20x
Quick Ratio 6.31x 9.91x 8.53x 22.57x 13.87x 4.49x 4.49x 1.28x
Operating Cash Flow Growth (YoY) -- -- -- -- -- -- -2083.3% --
Source: SEC EDGAR CompanyFacts (CIK 0001962011) · from September 30, 2023 Data through September 30, 2026 · synced Nov 21, 2026, 05:12 UTC · Open in terminal